Serial BNP Testing for Heart Failure Management
NCT00622531 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 108
Last updated 2015-11-17
Summary
The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.
Conditions
Interventions
- DEVICE
-
BNP assay (Siemens ADVIA Centaur BNP)
Diagnostic test
- OTHER
-
hidden BNP value
no intervention
Sponsors & Collaborators
-
Siemens Healthcare Diagnostics Inc
lead INDUSTRY
Principal Investigators
-
Denis C Phaneuf, MD · Centre Hospitalier de l'Université de Montréal (CHUM) Hôpital Hôtel Dieu
-
Serge Lepage, MD · Centre de recherche du Centre hospitalier universitaire de Sherbrooke
-
Boshara Zakhary, MD · Virginia Research Institute
-
Robert Dupuis, MD · Centre de santé et de services sociaux région de Thetford
-
Lee Marcus, MD · The Hudson Valley Heart Center
-
Thao Huynh, MD · McGill University Health Centre (MUHC) Montreal General Hospital
-
Nadia Giannetti, MD · McGill University Health Centre (MUHC) Royal Victoria Hospital
-
David Markham, MD · UT Southwestern Medical Center
-
Paul Heidenreich · Palo Alto VA Health Care System
-
William Little, MD · Wake Forest University Health Sciences
-
Eric Schaefer, MD · NYU Langone Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
NCT01625403 ·Status: UNKNOWN ·Phase: PHASE2
-
A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine
NCT01837849 ·Status: COMPLETED
-
Tezosentan in Acute Heart Failure
NCT00525707 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
NCT02388529 ·Status: WITHDRAWN ·Phase: PHASE1
-
CD-NP in Subjects With Stable Chronic Heart Failure
NCT00620308 ·Status: COMPLETED ·Phase: PHASE1
-
Biomarkers in Acute Heart Failure
NCT00537628 ·Status: COMPLETED
-
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
NCT03189901 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
NCT00745316 ·Status: TERMINATED ·Phase: PHASE2
-
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
NCT05919342 ·Status: RECRUITING ·Phase: NA
-
Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF
NCT00693745 ·Status: COMPLETED
-
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
NCT03357731 ·Status: COMPLETED ·Phase: PHASE2
-
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
NCT00186329 ·Status: COMPLETED ·Phase: PHASE4
-
Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure
NCT05111769 ·Status: UNKNOWN ·Phase: NA
-
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
NCT00271557 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
NCT00288730 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients
NCT01439789 ·Status: TERMINATED ·Phase: PHASE3
-
NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study
NCT04125966 ·Status: UNKNOWN
-
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
NCT00391846 ·Status: COMPLETED ·Phase: PHASE4
-
Spironolactone Therapy in Chronic Stable Right HF Trial
NCT03344159 ·Status: COMPLETED ·Phase: PHASE4
-
STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
NCT00484770 ·Status: COMPLETED ·Phase: PHASE2
-
B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice
NCT00130611 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
NCT00475852 ·Status: COMPLETED ·Phase: PHASE3
-
Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome
NCT03449888 ·Status: TERMINATED
-
Tezosentan in the Treatment of Acute Heart Failure
NCT00524433 ·Status: COMPLETED ·Phase: PHASE3
-
St. Vincent's Screening To Prevent Heart Failure Study
NCT00921960 ·Status: COMPLETED ·Phase: NA